December 12, 2024 21:38 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess | Devendra Fadnavis meets PM Modi amid suspense over Maharashtra portfolio allocation | Congress wants to deviate the issue of Sonia Gandhi-George Soros link: JP Nadda | Bengaluru techie suicide: Atul Subhash's family demanded Rs. 10 lakh as dowry leading to my father's death, claims estranged wife | Syria rebels torch tomb of ousted president Bashar al-Assad's father | Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal
Pfizer
Pixabay

US official expects COVID-19 vaccination to start on December 11

| @indiablooms | Nov 23, 2020, at 02:41 pm

Moscow/Sputnik: The first US citizens to receive Pfizer's COVID-19 vaccines may get the inoculation shot December 11, Operation Warp Speed chief adviser Moncef Slaoui told CNN on Sunday.

On Saturday, the US Pfizer has filed a request to the US Food and Drug Administration (FDA) for an emergency use authorization for the COVID-19 vaccine it developed in cooperation with German laboratory BioNTech. According to CNN, the FDA vaccine advisory committee is set for December 11.

"Our plan is to be able to ship vaccines to the immunization sites within 24 hours from the approval, so I expect maybe on day two after approval on the 11th or the 12th of December," Slaoui said as quoted by the media.

On Wednesday, Pfizer announced that the final analysis of the phase III clinical trials of the vaccine showed its 95 percent efficiency, and expected the FDA to enable the use of the vaccine in high-risk populations in late December.

Operation Warp Speed (OWS) is a public-private partnership established by the US government in May with an aim to produce and deliver 300 million doses of safe and effective vaccines with the initial doses available by January 2021. OWS includes the US Health Department, other federal agencies, research institutions and private firms, such as AstraZeneca, Johnson & Johnson's, Moderna and Pfizer.  

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.